Why researchers believe silver nanoparticles could \u2018revolutionize\u2019 medical imaging.<\/p>\n
1. Study Date and Source: Why researchers believe silver nanoparticles could \u2018revolutionize\u2019 medical imaging. 1. Study Date and Source: \u2022 Published on April 9, 2025 \u2022 Source: Health Imaging \u2022 Author: Hannah Murphy 2. Institution: \u2022 Research conducted at Oregon State University (OSU) 3. Research Focus: \u2022 Development of uniform silver nanoparticles to improve the targeting ability of CT contrast […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-6412","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/6412","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=6412"}],"version-history":[{"count":2,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/6412\/revisions"}],"predecessor-version":[{"id":6414,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/6412\/revisions\/6414"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=6412"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=6412"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=6412"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n\u2022 Published on April 9, 2025
\n\u2022 Source: Health Imaging
\n\u2022 Author: Hannah Murphy
\n2. Institution:
\n\u2022 Research conducted at Oregon State University (OSU)
\n3. Research Focus:
\n\u2022 Development of uniform silver nanoparticles to improve the targeting ability of CT contrast agents, especially for cancer imaging.
\n4. Lead Researcher:
\n\u2022 Marilyn Mackiewicz, PhD, associate professor of chemistry at OSU.
\n5. Medical Application:
\n\u2022 Goal is to use silver nanoparticles to track and highlight cancer cells during X-ray CT imaging by designing agents that selectively accumulate in cancerous tissue.
\n6. Scientific Challenge:
\n\u2022 Current silver nanoparticles vary in size and shape, making them unstable and unreliable for consistent medical use.
\n7. Innovative Solution:
\n\u2022 Using ultraviolet (UV) light, oxygen, and silver ions to convert particles into uniform triangle shapes.
\n\u2022 Coating them with a hybrid lipid membrane increases stability and biocompatibility.
\n8. Advantages:
\n\u2022 Uniform shape and size improve effectiveness, reliability, and safety.
\n\u2022 Potential to replace existing CT contrast agents with a more targeted, low-toxicity alternative.
\n9. Future Vision:
\n\u2022 These advancements could enable in vivo imaging with reduced toxicity risks.
\n\u2022 Researchers hope the findings will enhance nanoparticle synthesis for broader use in medical imaging and beyond. 1. Study Date and Source:
\n\u2022 Published on April 9, 2025
\n\u2022 Source: Health Imaging
\n\u2022 Author: Hannah Murphy
\n2. Institution:
\n\u2022 Research conducted at Oregon State University (OSU)
\n3. Research Focus:
\n\u2022 Development of uniform silver nanoparticles to improve the targeting ability of CT contrast agents, especially for cancer imaging.
\n4. Lead Researcher:
\n\u2022 Marilyn Mackiewicz, PhD, associate professor of chemistry at OSU.
\n5. Medical Application:
\n\u2022 Goal is to use silver nanoparticles to track and highlight cancer cells during X-ray CT imaging by designing agents that selectively accumulate in cancerous tissue.
\n6. Scientific Challenge:
\n\u2022 Current silver nanoparticles vary in size and shape, making them unstable and unreliable for consistent medical use.
\n7. Innovative Solution:
\n\u2022 Using ultraviolet (UV) light, oxygen, and silver ions to convert particles into uniform triangle shapes.
\n\u2022 Coating them with a hybrid lipid membrane increases stability and biocompatibility.
\n8. Advantages:
\n\u2022 Uniform shape and size improve effectiveness, reliability, and safety.
\n\u2022 Potential to replace existing CT contrast agents with a more targeted, low-toxicity alternative.
\n9. Future Vision:
\n\u2022 These advancements could enable in vivo imaging with reduced toxicity risks.
\n\u2022 Researchers hope the findings will enhance nanoparticle synthesis for broader use in medical imaging and beyond.
\n\ud83d\udd17 https:\/\/healthimaging.com\/topics\/medical-imaging\/imaging-contrast\/why-researchers-believe-silver-nanoparticles-could-revolutionize-medical-imaging<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"